12 completed, 5 unknown, 3 not yet recruiting, 2 active not recruiting. 25 Phase 2, 7 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 25 | Completed 12, Unknown 5, Not yet recruiting 3, Active not recruiting 2, Recruiting 2, Withdrawn 1 |
| Phase 1 | 7 | Completed 3, Unknown 3, Recruiting 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Minoxidil: new trials by email Literature Review of Minoxidil trials Research Report on Minoxidil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Minoxidil With or Without Low-Level Red-Light Therapy for Improving Chemotherapy-Induced Alopecia in Breast Cancer Patients Electronic Health Record Review, Minoxidil, Revian RED LED-light cap - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Not yet recruiting | Ohio State University Comprehensive Cancer Center | 50 | 2026-11-15 | 2026-09-02 |
| Comparative Study of Microneedling With Topical Minoxidil 5% ± NB-UVB in Stable Vitiligo" microneedling with minoxidil 5% and NBUVB, Microneedling with Minoxidil5% - Vitiligo - Macular Depigmentation | Phase 2 | Not yet recruiting | Sohag University | 30 | 2026-05-20 | 2026-04-29 |
| Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia Lactobacillus reuteri, Inactivated Lactobacillus reuteri, 5% Minoxidil - Androgenetic Alopecia (AGA) | Phase 2 | Recruiting | Shenzhen People's Hospital | 388 | 2026-01-25 | 2026-04-01 |
| A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes Human umbilical cord mesenchymal stem cell exosomes, Minoxidil 5% Topical Solution - Androgenic Alopecia | Phase 1 / Phase 2 | Recruiting | Shenzhen People's Hospital | 59 | 2025-09-20 | 2025-12-02 |
| A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia. Minoxidil 5% Topical Solution, PDFE-2304 Topical Solution - Alopecia, Androgenetic, Baldness | Phase 2 | Active not recruiting | PDFE Pharma Innovations FZCO | 15 | 2025-05-14 | 2025-06-08 |
| Various Procedural Treatment Options for Androgenetic Alopecia topical finasteride, Topical minoxidil - Androgenetic Alopecia | Phase 2 | Not yet recruiting | Sheikh Zayed Medical College | 190 | 2025-02-01 | 2025-02-13 |
| Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia minoxidil + finasteride, Placebo foam - Male Pattern of Hair Loss, Androgenic Alopecia, Androgenetic Alopecia (AGA) | Phase 2 | Completed | Beijing Dayspring Pharmaceutical Technology Co., Ltd | 110 | 2024-12-05 | 2026-03-03 |
| Toxicity and Efficacy Evaluation of Topical Minoxidil in Acne Vulgaris topical minoxidil in Acne Vulgaris - Acne Vulgaris | Phase 1 / Phase 2 | Unknown | Chang Gung Memorial Hospital | 26 | 2023-07-11 | 2023-11-03 |
| Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss Topical minoxidil, Topical Vitamin D, Saline spray - Dermatology, Female Pattern Baldness | Phase 1 / Phase 2 | Unknown | Sohag University | 45 | 2023-05-20 | 2024-03-27 |
| Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic Alopecia Finasteride, Minoxidil - Androgenetic Alopecia | Phase 2 / Phase 3 | Unknown | Universitas Indonesia | 40 | 2023-05-01 | 2023-09-22 |
| A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors Oral Minoxidil, Placebo - Survivors of Childhood Cancer, Alopecia | Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 10 | 2023-03-10 | 2026-02-20 |
| Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men prostaglandin F2a analogue in vehicle solution high dose, prostaglandin F2a analogue in vehicle solution low dose, active ingredient-free vehicle solution to DLQ01 - Androgenetic Alopecia | Phase 1 / Phase 2 | Completed | Dermaliq Therapeutics, Inc. | 120 | 2022-12-05 | 2024-04-08 |
| Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia Post-Laser Minoxidil 2%, At-Home Minoxidil 5%, Laser - Male Pattern Hair Loss, Androgenetic Alopecia | Phase 2 | Withdrawn | University of Minnesota | 2022-09-30 | 2023-09-13 | |
| Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer Minoxidil - Ovarian Cancer | Phase 2 | Unknown | Loyola University | 34 | 2021-12-13 | 2023-10-05 |
| Topical Cetirizine in Androgenetic Alopecia in Females Topical cetirizine, Placebo, Topical minoxidil - Androgenetic Alopecia | Phase 2 / Phase 3 | Completed | Cairo University | 66 | 2020-07-25 | 2023-02-08 |
| ENERGI-F701 for Female Hair Loss Treatment ENERGI-F701, Regaine - Female Pattern Baldness, Hair Loss | Phase 2 | Completed | Energenesis Biomedical Co., Ltd. | 67 | 2018-05-23 | 2020-11-24 |
| Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women Platelet Rich Plasma, Minoxidil Foam - Alopecia | Phase 1 / Phase 2 | Completed | Mayo Clinic | 20 | 2017-01-23 | 2020-04-08 |
| Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application DA-4001C, 5% minoxidil - Androgenetic Alopecia | Phase 1 / Phase 2 | Completed | Dong-A ST Co., Ltd. | 60 | 2014-01-01 | 2015-06-24 |
| A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss Pantovigar, Minoxidil 2% only - Female Pattern Hair Loss, Androgenetic Alopecia (AGA) | Phase 2 | Completed | Merz Pharmaceuticals GmbH | 74 | 2012-04-01 | 2013-12-12 |
| A Study to Determine the Safety and Efficacy of Autologous Human Platelet Lysate for Treatment of Androgenetic Alopecia Autologous Human Platelet Lysate (HPL), 2 % Minoxidil and /or Finasteride - Androgenetic Alopecia | Phase 1 / Phase 2 | Unknown | Kasiak Research Pvt. Ltd. | 20 | 2012-01-01 | 2012-07-25 |
Showing 20 of 25. Sign in to see all of them.
Alopecia (19) · Acne Vulgaris (1) · Bulbo-Spinal Atrophy, X-Linked (1) · Carcinoma, Ovarian Epithelial (1) · Cardiovascular Abnormalities (1) · Ovarian Neoplasms (1) · Williams Syndrome (1)
Allergan (2) · Shenzhen People's Hospital (2) · Sohag University (2) · Beijing Dayspring Pharmaceutical Technology Co., Ltd (1) · Cairo University (1) · Chang Gung Memorial Hospital (1) · Dermaliq Therapeutics, Inc. (1) · Dong-A ST Co., Ltd. (1) · Energenesis Biomedical Co., Ltd. (1) · Hospices Civils de Lyon (1) · Kasiak Research Pvt. Ltd. (1) · Loyola University (1) · Mayo Clinic (1) · Memorial Sloan Kettering Cancer Center (1) · Merz Pharmaceuticals GmbH (1)
United States (7) · China (3) · Germany (3) · Egypt (2) · India (2) · Taiwan (2) · Australia (1) · Canada (1) · France (1) · Indonesia (1) · Pakistan (1) · Russia (1) · South Korea (1)
Alina Markova, MD (1) · Alison Bruce, M.B. Ch.B (1) · Betsy Hughes-Formella, PhD (1) · Brittany L Dulmage, MD (1) · Cheng Zhou, MD, PhD (1) · Cheng-Lung Hsu, Profesor (1) · Essam A Nada, MD (1) · Hanan Nada, PhD (1) · Hoon Kang, M.D, Ph.D (1) · Jerry Shapiro, MD (1) · Jianzhong Zhang, MD, PhD (1) · Maggie Abbassi, PhD (1) · Margaret Liotta, DO (1)